000 | 01001 a2200289 4500 | ||
---|---|---|---|
005 | 20250514213346.0 | ||
264 | 0 | _c20050706 | |
008 | 200507s 0 0 eng d | ||
022 | _a0012-186X | ||
024 | 7 |
_a10.1007/s00125-004-1616-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFerrannini, E | |
245 | 0 | 0 |
_aRosiglitazone and lipid metabolism. _h[electronic resource] |
260 |
_bDiabetologia _cJan 2005 |
||
300 |
_a6-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 |
_aAdipose Tissue _xmetabolism |
650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 | _aLipid Metabolism |
650 | 0 | 4 |
_aPeroxisome Proliferator-Activated Receptors _xphysiology |
650 | 0 | 4 | _aRosiglitazone |
650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
773 | 0 |
_tDiabetologia _gvol. 48 _gno. 1 _gp. 6-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-004-1616-z _zAvailable from publisher's website |
999 |
_c15304778 _d15304778 |